Vol. 4, Issue 1 (2015)
Cost-analysis of psychotropic drugs prescribed for the patients with schizophrenia in a university teaching hospital
Juno J. Joel, Shastry C.S, Satheesh Rao
The study deals with the pharmacoeconomic assessment of schizophrenia. The cost of management of schizophrenia has been measured with a special concern to the cost of drugs prescribed for the treatment. The study has been conducted in a tertiary care teaching hospital of Dakshina Kannada, India. The study group includes in-patients who have been diagnosed with schizophrenia and admitted for the treatment of the same. An effort has been made to discover the direct cost acquired for the treatment of schizophrenia. In this study it has been observed that the utilization of olanzapine and the cost acquired by the same drug was found to be the highest (Rs. 31985.80) during the study period. When we calculated the cost of drugs prescribed from the hospital we found that the minimum cost of drug therapy per month was Rs. 75 for olanzapine and the same drug with other brand was Rs. 335.7. The cost index (CI) of Levosulpride was the lowest CI (1.07 times) and that of diazepam was the highest (11.04 times). Cost of different brands of psychotropic drugs available in the market was found to be 3 to 10 times higher between brands. The extent of difference observed in our study is a matter of concern.This highlights the need to prescribe generic drugs and choose brands that offer good quality low cost drugs.
How to cite this article:
Juno J. Joel, Shastry C.S, Satheesh Rao. . The Pharma Innovation Journal. 2015; 4(1): 67-70.